UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment

International journal of molecular sciences, 2024-10, Vol.25 (19), p.10652

2024

Volltextzugriff (PDF)

Structure Prediction, Evaluation, and Validation of GPR18 Lipid Receptor Using Free Programs

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7917

2022

Volltextzugriff (PDF)

The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12719

2023

Volltextzugriff (PDF)

Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties

Molecules (Basel, Switzerland), 2021-04, Vol.26 (8), p.2300

2021

Volltextzugriff (PDF)

AR71, Histamine H3 Receptor Ligand—In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action)

International journal of molecular sciences, 2024-08, Vol.25 (15), p.8035

2024

Volltextzugriff (PDF)

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity

International journal of molecular sciences, 2023-09, Vol.24 (18), p.13707

2023

Volltextzugriff (PDF)

Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease

Molecules (Basel, Switzerland), 2022-12, Vol.28 (1), p.238

2022

Volltextzugriff (PDF)

Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014

Current medicinal chemistry, 2014-01, Vol.21 (34), p.3962-3975

2014

Volltextzugriff (PDF)

Dual-targeting Approach on Histamine H 3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders

Current medicinal chemistry, 2021, Vol.28 (15), p.2974

2021

Volltextzugriff (PDF)

Histamine H3 Receptor Ligands—KSK-59 and KSK-73—Reduce Body Weight Gain in a Rat Model of Excessive Eating

Pharmaceuticals (Basel, Switzerland), 2021-10, Vol.14 (11), p.1080

2021

Volltextzugriff (PDF)

Molecular Modeling of an Orphan GPR18 Receptor

Letters in drug design & discovery, 2019-01, Vol.16 (10), p.1167-1174

2019

Volltextzugriff (PDF)

Docking Foundations: From Rigid to Flexible Docking

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2780, p.3

Kuder, Kamil J

2024

Volltextzugriff (PDF)

Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders

Current medicinal chemistry, 2021-01, Vol.28 (15), p.2974-2995

2021

Volltextzugriff (PDF)

Machine Learning Methods in Protein-Protein Docking

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2780, p.107

2024

Volltextzugriff (PDF)

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand

Pharmacological reports, 2023-10, Vol.75 (5), p.1211-1229

2023

Volltextzugriff (PDF)

The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice

Naunyn-Schmiedeberg's archives of pharmacology, 2018-08, Vol.391 (8), p.875-881

2018

Volltextzugriff (PDF)

Autonomous gauge for blast impulse determination close to explosive charges

Shock waves, 2016-03, Vol.26 (2), p.117-127

2016

Volltextzugriff (PDF)

N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H 3 receptor and cancer resistance proteins

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (22), p.127522

2020

Volltextzugriff (PDF)

N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (22), p.127522-127522, Article 127522

2020

Volltextzugriff (PDF)

Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands

European journal of medicinal chemistry, 2018-05, Vol.152, p.223-234

2018

Volltextzugriff (PDF)

Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent

European journal of medicinal chemistry, 2021-03, Vol.213, p.113041, Article 113041

2021

Volltextzugriff (PDF)

Structural modifications in the distal, regulatory region of histamine H 3 receptor antagonists leading to the identification of a potent anti-obesity agent

European journal of medicinal chemistry, 2021-03, Vol.213, p.113041

2021

Volltextzugriff (PDF)

The histamine H 3 receptor inverse agonist pitolisant reduces body weight in obese mice

Naunyn-Schmiedeberg's archives of pharmacology, 2018-08, Vol.391 (8), p.875

2018

Volltextzugriff (PDF)

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (15), p.1591

2016

Volltextzugriff (PDF)

Optimization and preclinical evaluation of novel histamine H 3 receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives

Bioorganic & medicinal chemistry, 2018-12, Vol.26 (23-24), p.6056

2018

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(184)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment

Structure Prediction, Evaluation, and Validation of GPR18 Lipid Receptor Using Free Programs

The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice

Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties

AR71, Histamine H3 Receptor Ligand—In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action)

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity

Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease

Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014

Dual-targeting Approach on Histamine H 3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders

Histamine H3 Receptor Ligands—KSK-59 and KSK-73—Reduce Body Weight Gain in a Rat Model of Excessive Eating

Molecular Modeling of an Orphan GPR18 Receptor

Docking Foundations: From Rigid to Flexible Docking

Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders

Machine Learning Methods in Protein-Protein Docking

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand

The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice

Autonomous gauge for blast impulse determination close to explosive charges

N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H 3 receptor and cancer resistance proteins

N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins

Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands

Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent

Structural modifications in the distal, regulatory region of histamine H 3 receptor antagonists leading to the identification of a potent anti-obesity agent

The histamine H 3 receptor inverse agonist pitolisant reduces body weight in obese mice

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial

Optimization and preclinical evaluation of novel histamine H 3 receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives

Suchergebnisse filtern